Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems

J Neurosci Methods. 2020 Jan 15:330:108458. doi: 10.1016/j.jneumeth.2019.108458. Epub 2019 Oct 12.

Abstract

Smoking tobacco products is the leading cause of preventable death worldwide. Coordinated efforts have successfully reduced tobacco cigarette smoking in the United States; however, electronic cigarettes (e-cigarette) and other electronic nicotine delivery systems (ENDS) recently have replaced traditional cigarettes for many users. While the clinical risks associated with long-term ENDS use remain unclear, advancements in preclinical rodent models will enhance our understanding of their overall health effects. This review examines the peripheral and central effects of ENDS-mediated exposure to nicotine and other drugs of abuse in rodents and evaluates current techniques for implementing ENDS in preclinical research.

Keywords: E-cigarette; ENDS; Mouse; Nicotine; Rat; Vaping.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / adverse effects*
  • Disease Models, Animal
  • Electronic Nicotine Delivery Systems*
  • Nicotine / administration & dosage
  • Nicotine / adverse effects*
  • Peripheral Nervous System Agents / administration & dosage
  • Peripheral Nervous System Agents / adverse effects*
  • Rats
  • Rodentia
  • Vaping / adverse effects*

Substances

  • Central Nervous System Stimulants
  • Peripheral Nervous System Agents
  • Nicotine